330 related articles for article (PubMed ID: 23800495)
41. Edaravone in acute ischemic stroke.
Kitagawa Y
Intern Med; 2006; 45(5):225-6. PubMed ID: 16595983
[No Abstract] [Full Text] [Related]
42. Free radical trapping as a therapeutic approach to neuroprotection in stroke: experimental and clinical studies with NXY-059 and free radical scavengers.
Green AR; Ashwood T
Curr Drug Targets CNS Neurol Disord; 2005 Apr; 4(2):109-18. PubMed ID: 15857295
[TBL] [Abstract][Full Text] [Related]
43. [Research and development of the free radical scavenger edaravone as a neuroprotectant].
Watanabe T; Tanaka M; Watanabe K; Takamatsu Y; Tobe A
Yakugaku Zasshi; 2004 Mar; 124(3):99-111. PubMed ID: 15049127
[TBL] [Abstract][Full Text] [Related]
44. Efficacy of edaravone, a free radical scavenger, for the treatment of acute lacunar infarction.
Mishina M; Komaba Y; Kobayashi S; Tanaka N; Kominami S; Fukuchi T; Mizunari T; Hamamoto M; Teramoto A; Katayama Y
Neurol Med Chir (Tokyo); 2005 Jul; 45(7):344-8; discussion 348. PubMed ID: 16041179
[TBL] [Abstract][Full Text] [Related]
45. Haptoglobin Administration in Cardiovascular Surgery Patients: Its Association With the Risk of Postoperative Acute Kidney Injury.
Kubota K; Egi M; Mizobuchi S
Anesth Analg; 2017 Jun; 124(6):1771-1776. PubMed ID: 28525506
[TBL] [Abstract][Full Text] [Related]
46. Risk factors for poor outcome and mortality at 3 months after the ischemic stroke in patients with atrial fibrillation.
Li S; Zhao X; Wang C; Liu L; Liu G; Wang Y; Wang C; Jing J; Wang YJ
J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e419-25. PubMed ID: 23721617
[TBL] [Abstract][Full Text] [Related]
47. Intracranial arterial calcification can predict early vascular events after acute ischemic stroke.
Lee JG; Lee KB; Roh H; Ahn MY; Bae HJ; Lee JS; Woo HY; Hwang HW
J Stroke Cerebrovasc Dis; 2014; 23(5):e331-7. PubMed ID: 24560247
[TBL] [Abstract][Full Text] [Related]
48. [Pharmacological and clinical profile of the free radical scavenger edaravone as a neuroprotective agent].
Tanaka M
Nihon Yakurigaku Zasshi; 2002 May; 119(5):301-8. PubMed ID: 12061142
[TBL] [Abstract][Full Text] [Related]
49. Edaravone attenuates white matter lesions through endothelial protection in a rat chronic hypoperfusion model.
Ueno Y; Zhang N; Miyamoto N; Tanaka R; Hattori N; Urabe T
Neuroscience; 2009 Aug; 162(2):317-27. PubMed ID: 19409967
[TBL] [Abstract][Full Text] [Related]
50. Cost-effectiveness analysis of the neuroprotective agent edaravone for noncardioembolic cerebral infarction.
Shinohara Y; Inoue S
J Stroke Cerebrovasc Dis; 2013 Jul; 22(5):668-74. PubMed ID: 22622391
[TBL] [Abstract][Full Text] [Related]
51. Quality of acute ischemic stroke care in Thailand: a prospective multicenter countrywide cohort study.
Nilanont Y; Nidhinandana S; Suwanwela NC; Hanchaiphiboolkul S; Pimpak T; Tatsanavivat P; Saposnik G; Poungvarin N;
J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):213-9. PubMed ID: 23305673
[TBL] [Abstract][Full Text] [Related]
52. Unemployment: a social risk factor associated with early ischemic stroke mortality? Results from the Argentinean National Stroke Registry (ReNACer).
Sposato LA; Ioli P; Povedano G; Esnaola y Rojas MM; Saposnik G;
J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):679-83. PubMed ID: 21482141
[TBL] [Abstract][Full Text] [Related]
53. Experimental study on the protective effects of edaravone against ischemic spinal cord injury.
Suzuki K; Kazui T; Terada H; Umemura K; Ikeda Y; Bashar AH; Yamashita K; Washiyama N; Suzuki T; Ohkura K; Yasuike J
J Thorac Cardiovasc Surg; 2005 Dec; 130(6):1586-92. PubMed ID: 16308003
[TBL] [Abstract][Full Text] [Related]
54. Safety, tolerability and pharmacokinetics of MCI-186 in patients with acute ischemic stroke: new formulation and dosing regimen.
Kaste M; Murayama S; Ford GA; Dippel DW; Walters MR; Tatlisumak T;
Cerebrovasc Dis; 2013; 36(3):196-204. PubMed ID: 24135530
[TBL] [Abstract][Full Text] [Related]
55. Edaravone inhibits the disease activity in rheumatoid arthritis.
Arii K; Kumon Y; Ikeda Y; Suehiro T; Hashimoto K
J Clin Pharm Ther; 2006 Apr; 31(2):197-9. PubMed ID: 16635056
[TBL] [Abstract][Full Text] [Related]
56. Effect of edaravone, a free radical scavenger, on ischemic cerebral edema assessed by magnetic resonance imaging.
Suda S; Igarashi H; Arai Y; Andou J; Chishiki T; Katayama Y
Neurol Med Chir (Tokyo); 2007 May; 47(5):197-201; discussion 201-2. PubMed ID: 17527045
[TBL] [Abstract][Full Text] [Related]
57. Prestroke glycemic control is associated with the functional outcome in acute ischemic stroke: the Fukuoka Stroke Registry.
Kamouchi M; Matsuki T; Hata J; Kuwashiro T; Ago T; Sambongi Y; Fukushima Y; Sugimori H; Kitazono T;
Stroke; 2011 Oct; 42(10):2788-94. PubMed ID: 21817134
[TBL] [Abstract][Full Text] [Related]
58. Effects of edaravone on reperfusion injury in patients with acute myocardial infarction.
Tsujita K; Shimomura H; Kawano H; Hokamaki J; Fukuda M; Yamashita T; Hida S; Nakamura Y; Nagayoshi Y; Sakamoto T; Yoshimura M; Arai H; Ogawa H
Am J Cardiol; 2004 Aug; 94(4):481-4. PubMed ID: 15325934
[TBL] [Abstract][Full Text] [Related]
59. Edaravone, a free radical scavenger, in the treatment of idiopathic sudden sensorineural hearing loss with profound hearing loss.
Sano H; Kamijo T; Ino T; Okamoto M
Auris Nasus Larynx; 2010 Feb; 37(1):42-6. PubMed ID: 19570630
[TBL] [Abstract][Full Text] [Related]
60. Edaravone - citicoline comparative study in acute ischemic stroke (ECCS-AIS).
Mitta M; Goel D; Bansal KK; Puri P
J Assoc Physicians India; 2012 Nov; 60():36-8. PubMed ID: 23767201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
